Skip to Main Content

1,214

Views

0

CrossRef citations to date

0

Altmetric

Article

Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry

Jonathan I. Silverberga George Washington University School of Medicine and Health Sciences, DC, USACorrespondence[email protected]
View further author information

,

Evangeline Pierceb Eli Lilly and Company, IN, USAView further author information

,

Meghan Feelyb Eli Lilly and Company, IN, USA;c Mount Sinai Hospital, NY, USAView further author information

,

Amber Reck Atwaterb Eli Lilly and Company, IN, USAView further author information

,

Amy Schraderd CorEvitas LLC, MA, USAView further author information

,

Eric A. Jonesd CorEvitas LLC, MA, USAView further author information

,

Swapna S. Daved CorEvitas LLC, MA, USAView further author information

&

Eric L. Simpsone Oregon Health & Science University, OR, USAView further author information